News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn I-Corps Fall 2026 Cohort
The Fall 2026 Penn I-Corps cohort includes ten teams working in devices, therapeutics, diagnostics, IT, and materials.
Penn Engineering Researchers Use AI to Improve a Gene-Editing Tool
EvoMax uses experimental data to predict which modifications could improve the tool without having to test thousands of possibilities individually.
Penn Vet Researchers Invent Skin‑targeted Dual mRNA Vaccine Platform to Deliver Long‑lasting Protection Against Cutaneous Leishmaniasis
This experimental vaccine uses mRNA technology to train immune cells to recognize the parasite that causes cutaneous.
Penn Engineering researchers are developing new genetic technologies designed to make treating complex diseases simpler
In the field of bioengineering, Penn researchers are leveraging AI to improve gene editing tools and genetic engineering.
Penn Faculty Weighs in On the Future of American Science
John Wherry, PhD, the Richard and Barbara Schiffrin President's Distinguished Professor at Penn Medicine, explains how decades of federal funding for basic science enabled breakthroughs.
Penn Partners in New National Science Foundation AI Institute for Human-AI Cooperation
The institute will bring together more than 40 partners across academia, industry, government, healthcare, and nonprofit organizations to transform the role of AI in healthcare.
Penn Partners with Six Pennsylvania Research Universities, the Pittsburgh Supercomputing Center, and the State of Pennsylvania to Drive AI and Quantum Research
This collaboration, known as Keystone AI + Quantum Factory, will allow institutions to share high-end computing infrastructure and pursue commercial applications for emerging technologies.
PA State Budget Passes with $125 million Investment in Pennsylvania’s Life Sciences Industry
The budget includes the Innovate in PA 2.0 Program, which will provide capital for startups, fund clinical trials for life sciences and improve the Commonwealth's innovation network.
CAR T Cell Therapy for Lymphoma Leads to 10 Year Remissions for Patients
The follow-up study of patients ten years later showed promising results.
ARPA-H Awards $43 million to Philadelphia Gene Therapy Researchers to Advance Rare Disease Treatments
Learn more about the recipients.